Synthesis and purification of oligoribonucleotides using T4 RNA ligase and reverse-phase chromatography
- PMID: 3985307
- DOI: 10.1016/0003-2697(85)90091-0
Synthesis and purification of oligoribonucleotides using T4 RNA ligase and reverse-phase chromatography
Abstract
T4 RNA ligase has been used to construct a series of defined oligoribonucleotides. Hexamer or pentamer blocks were synthesized first by multiple additions of mononucleotide diphosphates to trimers with T4 RNA ligase and removal of the terminal phosphate with alkaline phosphatase; inhibitors of the ligase were removed by passing the sample over a 1-ml reverse-phase octadecasilyl column. The two nucleotide blocks were then ligated to give undecamers. Yields for the individual ligations ranged from 85 to 100% for acceptors lacking uridines and at least 70% for those containing uridines. The overall yield of the undecamer relative to the starting trimers was about 10%. Each round of ligation averaged about 8 h; the time required to synthesize each undecamer was 1 to 2 weeks. Optimization of the steps to achieve this is described in detail.
Similar articles
-
Reversal of T4 RNA ligase.Biochemistry. 1982 Apr 13;21(8):1858-64. doi: 10.1021/bi00537a024. Biochemistry. 1982. PMID: 7082652
-
The effect of acceptor oligoribonucleotide sequence on the T4 RNA ligase reaction.Eur J Biochem. 1982 Jul;125(3):639-43. doi: 10.1111/j.1432-1033.1982.tb06730.x. Eur J Biochem. 1982. PMID: 7117259
-
Joining of 3'-modified oligonucleotides by T4 RNA ligase. Synthesis of a heptadecanucleotide corresponding to the bases 61--77 from Escherichia coli tRNAfMet.Biochemistry. 1978 Nov 14;17(23):4894-9. doi: 10.1021/bi00616a006. Biochemistry. 1978. PMID: 363145
-
T4 RNA ligase as a nucleic acid synthesis and modification reagent.Gene Amplif Anal. 1981;2:313-45. Gene Amplif Anal. 1981. PMID: 6765649 Review. No abstract available.
-
DNA-joining enzymes: a review.Methods Enzymol. 1979;68:50-71. doi: 10.1016/0076-6879(79)68006-0. Methods Enzymol. 1979. PMID: 232224 Review. No abstract available.
Cited by
-
Synthetic circRNA therapeutics: innovations, strategies, and future horizons.MedComm (2020). 2024 Nov 9;5(11):e720. doi: 10.1002/mco2.720. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39525953 Free PMC article. Review.
-
In vitro circularization of RNA.RNA Biol. 2017 Aug 3;14(8):1018-1027. doi: 10.1080/15476286.2016.1239009. Epub 2016 Sep 26. RNA Biol. 2017. PMID: 27668458 Free PMC article. Review.
-
Computational analysis of fitness landscapes and evolutionary networks from in vitro evolution experiments.Methods. 2016 Aug 15;106:86-96. doi: 10.1016/j.ymeth.2016.05.012. Epub 2016 May 19. Methods. 2016. PMID: 27211010 Free PMC article.
-
Polyadenylation ligation-mediated sequencing (PALM-Seq) characterizes cell-free coding and non-coding RNAs in human biofluids.Clin Transl Med. 2022 Jul;12(7):e987. doi: 10.1002/ctm2.987. Clin Transl Med. 2022. PMID: 35858042 Free PMC article.
-
Probing the function of conserved RNA structures in the 30S subunit of Escherichia coli ribosomes.Nucleic Acids Res. 1991 Dec 25;19(24):6895-903. doi: 10.1093/nar/19.24.6895. Nucleic Acids Res. 1991. PMID: 1662366 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources